RSS GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts

Currently reading:
 RSS GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts

Status
Not open for further replies.
Crax Bot

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
15,386
Likes
1,923
Credits
33,933©
Cash
0$
GSK plc (ticker: GSK, GSK.L) has announced that the European Commission has granted approval for Jemperli in combination with chemotherapy as a first-line treatment. This is intended for adult patients with both primary advanced and recurrent endometrial cancer who are eligible for systemic therapy. The approval extends the previous indication for using Jemperli alongside chemotherapy within the EU, now including patients with mismatch repair proficient or microsatellite stable tumors.

The company also highlighted that in August 2024, the US label for Jemperli plus chemotherapy was expanded to cover all adult patients with both primary advanced and recurrent endometrial cancer.

The material has been provided by InstaForex Company - www.instaforex.com
Click to read more...
 
Status
Not open for further replies.

Similar threads

Crax Bot
  • Locked
RSS AstraZeneca And Daiichi Sankyo's Datroway Gets US Approval For Metastatic HR+ Breast Cancer
Replies
0
Views
27
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS Johnson & Johnson's RYBREVANT Plus Chemotherapy Approved In Canada For Advanced Lung Cancer
Replies
0
Views
16
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS GSK Reports Headline Results From FIRST-ENGOT-OV44 Phase III Trial - Quick Facts
Replies
0
Views
31
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer
Replies
0
Views
17
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS GSK To Acquire GIST Drug Developer IDRx For Up To $1.15 Bln Cash
Replies
0
Views
18
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS FDA To Decide On Verastem's Avutometinib & Defactinib For A Subtype Of Serous Ovarian Cancer In June
Replies
0
Views
30
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS Verastem Oncology's Ovarian Cancer Treatment Gets FDA Priority Review
Replies
0
Views
48
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS Astellas Pharma : China's NMPA Approves VYLOY For Advanced Gastric/Gastroesophageal Junction Cancer
Replies
0
Views
26
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS BeiGene Announces FDA Approval Of TEVIMBRA - Quick Facts
Replies
0
Views
35
Crax Bot
Crax Bot
Crax Bot
  • Locked
RSS Incyte And Syndax : FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes
Replies
0
Views
10
Crax Bot
Crax Bot
Top Bottom
    • Tools : Download Tools from our Resources.
    Configs : Download Configs[ob/ob2/svb/cyb/anom].
    Memes : Bored? Lets have some Memes (⁠◠⁠‿⁠◕⁠)
    Crax.Tube : 1st LEARN... Then remove the "L".
    NSFW : I stay away from the internet as much
                                               as I can. Except for PORN.
    Upgrade : Just £15 to access everything NOW!
    Earn : Low on Money?Start Earning from Crax Now!
    Crax.Shop : Buy/Sell without getting Scammed 💯